LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 19 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $422,000 | +20.2% | 113,500 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $351,000 | -42.1% | 113,500 | 0.0% | 0.01% | -40.0% |
| Q1 2022 | $606,000 | +9.4% | 113,500 | 0.0% | 0.01% | +42.9% |
| Q4 2021 | $554,000 | -44.8% | 113,500 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $1,004,000 | -3.0% | 113,500 | 0.0% | 0.01% | +10.0% |
| Q2 2021 | $1,035,000 | -78.9% | 113,500 | -62.2% | 0.01% | -78.3% |
| Q1 2021 | $4,914,000 | – | 300,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |